Diseases across multiple systems

There is 1 paper on diseases across multiple systems in aging research: 1 observational study in people. The newest story, Nov 3, 2026: “Faster brain aging linked to death and disease across the body”.

Disease

1 paper studies it3 more mention it1 finding

2 new papers in 30 daysSee all 4 papers on diseases across multiple systems

“The polygenic risk score for BAA demonstrated significant associations with mortality and diseases across multiple systems in the non-GWAS cohort.”
Integrative analysis of brain-age acceleration: health associations and multi-omics profilesNPJ aging2026doi:10.1038/s41514-026-00557-5
  • Humans1

Associations

1

Polygenic risk score for brain-age acceleration

mixedin humans1

1 study
  1. Polygenic risk score for brain-age acceleration is associated with diseases across multiple systems in the non-GWAS cohort.

    “The polygenic risk score for BAA demonstrated significant associations with mortality and diseases across multiple systems in the non-GWAS cohort.”

    Humansin the non-GWAS cohort

    Faster brain aging linked to death and disease across the body

    NPJ aging

More on Polygenic risk score for brain-age acceleration

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 1Nov 2026: 14 papers in 12 months
NPJ Aging

Faster brain aging linked to death and disease across the body

An observational analysis of brain scans from over 60,000 UK Biobank participants linked accelerated brain aging to death and diseases affecting multiple organ systems.An observational analysis of brain scans from over 60,000 UK Biobank participants linked accelerated brain aging to death and diseases affecting multiple organ systems.

Cohort studyBiomarkers
medRxiv

Frailty linked to faster buildup of chronic diseases

Frailty was linked to higher risk of 458 of 536 chronic diseases in participants followed for a median of 13.8 years.Frailty was linked to higher risk of 458 of 536 chronic diseases in participants followed for a median of 13.8 years.

Preprint: cohort · 466,864 peoplePopulations